|
|
| | | | Dear colleagues,
| | | | | | Please save the date for the 13th International Symposium on Hodgkin Lymphoma (ISHL13) which will take place in the Gürzenich Hall Conference Center in Cologne, Germany, from October 26 to 28, 2024.
| | | | | | ISHL13 will bring together professionals across the globe to meet and discuss cutting-edge research in the field of Hodgkin Lymphoma. Clinicians, scientists and patients from more than 50 countries participated in the last conference, which featured more than 100 scientific abstracts.
| | | | | | ISHL13 will provide a comprehensive overview on the latest advances in biology, clinical research, diagnostics and treatment of Hodgkin Lymphoma. In addition to the main scientific program featuring presentation of novel research and educational updates, workshops, interactive case discussions and satellite symposia will be held from October 26 to 28, 2024. Moreover, an educational track focusing on “Emerging Therapeutic Concepts in B-Cell Lymphomas” will complement the ISHL13 program.
| | | | |
|
|
| We look forward to meeting you for ISHL13 in Cologne in 2024.
| | | | | | Peter Borchmann, MD,
Symposium and GHSG Chairman | |
Sven Borchmann, MD/PhD,
Symposium Co-Chair | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
| | | | |
|
 |
|
|